Compare ARK Genomic Revolution ETF (ARKG) vs Eni SpA (E) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Eni SpA — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Eni SpA trades at $48.42 (market cap $68.81B). The key difference: Eni SpA pays a 5.12% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Eni SpA nearer its low. Which is the better fit depends on your goals.
| ARKG | E | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $57.61 |
52-Week Low | $23.09 | $32.93 |
Market Cap | — | $68.81B |
Enterprise Value | — | $87.72B |
Dividend Yield | — | 5.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
E trades at $47.72, down 0.4% on the day, with a bullish technical signal despite recent earnings volatility. The company maintains stable cash flows with $238M net cash flow in 2025 and a dividend yield of 1.3%. Recent strategic moves include lithium investments in Chile and energy trading partnerships, diversifying beyond traditional oil and gas operations. Valuation metrics appear attractive with P/E of 21.05 and P/S of 0.77, though revenue has declined from $132.5B in 2022 to $82.2B in 2025.
The outlook balances value opportunities against execution risks. Analysts show cautious optimism with 34.6% buy ratings, but declining revenue and margin pressure pose challenges. Key catalysts include successful integration of new energy ventures and oil price stability, while geopolitical tensions and energy transition costs represent significant headwinds for near-term performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
